In continuing our program aimed to search for tyrosinase inhibitors, a series of novel 4-O-substituted phenylmethylenethiosemicarbazones were rational designed, synthesized and their inhibitory effects on the diphenolase activity of mushroom tyrosinase were also evaluated. A fair number of compounds were found to have significant tyrosinase inhibitiory activity. Particularly, the IC 50 values of compounds 3a-g, 3j and 3s were of the same magnitude as tropolone, one of the best tyrosinase inhibitors known so far. Furthermore, the structure-activity relationships of these compounds were also investigated. All these data suggested that these molecules might be utilized for the development of new candidate for the treatment of dermatological disorders, and further development of such compounds may be of interest.
Tyrosinase or polyphenol oxidase (EC 1.14.18.1), a multifunctional type-3 copper-containing metalloenzyme, is widely distributed in nature. 1, 2) It has a diverse roles in agriculture, the cosmetic industry and medicine.
3) The enzyme catalyzes two reactions in the melanin biosynthesis pathway involving molecular oxygen: the hydroxylation of monophenols to odiphenols (cresolase/monophenolase activity) and the oxidation of o-diphenols to o-quinones (catecholase/diphenolase activity). The produced quinones are highly reactive and can further oxidized spontaneously to form brown pigments of high molecular weight, namely melanin, which are responsible for mammalian skin and hair color. 3) However, recently studies showed that the abnormal accumulation of pigmentation causes the quality loss of vegetables and fruits and various dermatological disorders, such as hyperpigmentation, freckles, melasma, ephelide, and senile lentigines. 4) Furthermore, the melanin pigments are also found in the mammalian brain where tyrosinase plays a key role in the synthesis of neuromelanin and is linked to Parkinson's and other neurodegenerative diseases. 4, 5) Therefore, tyrosinase inhibitors should be clinically useful for the treatment of some dermatological disorders associated with melanin hyperpigmentation and also important in cosmetics and food industry. [6] [7] [8] So far, a large number of potential tyrosinase inhibitors have been described from natural source, such as kojic acid (Fig. 1) , 9) corticosteroids, 10) retinoids, 10) arbutin, 10) tropolone (Fig. 1) . 11, 12) Unfortunately, only few of these reported compounds are used in practice because of their lower activities or serious side effects. Therefore, it is still necessary to search and discover novel tyrosinase inhibitors with higher activity and lower side effect by laboratory synthesis. 13) In previous reports, some functionalized 4-alkoxybenzaldehyde derivatives have been presented as potent tyrosinase inhibitors, and further study suggested that the electron-donating groups at C-4 are necessary for the actions. 14, 15) Recently, our investigation [16] [17] [18] [19] demonstrated that thiosemicarbzide derivatives exhibited profound tyrosinase inhibitory activities because of their strong interaction with the dicopper ions active center of tyrosinase. For example, phenylmethylenethiosemicarbazone ( Fig. 1) showed a potent tyrosianse inhibitory activity with the IC 50 value of 1.93 mM. 19) In addition, it was worth noting that, on the basis of the reported crystallographic structure of tyrosinase, Khatib et al. designed and synthesized a series of 3-(2,4-dihydroxyphenyl)propionic acid esters as tyrosinase inhibitors, and the results showed that these compounds have significant activities against tyrosinase. 4) This finding emphasized the possibility that a hydrophobic moiety may also contribute to the inhibition.
Taking advantage of above information, we speculated that the introduction of a proper hydrophobic subunit to position-4 of phenylmethylenethiosemicarbazone, may interact with the hydrophobic enzyme pocket and the dicopper ions active center of tyrosinase, leading to increased inhibitor-enzyme binding affinity, and thus to an improved compound activity. Therefore, in the present study, a series of 4-O-substituted phenylmethylenethiosemicarbazones were designed, synthesized and their inhibitory effects on the diphenolase activity of mushroom tyrosinase were evaluated. Moreover, the structure-activity relationships of these compounds were also discussed. We hope that these findings can lead to the discovery of food preservatives and therapeutically potent agents against clinically dermatological disorders including hyperpigmentation as well as skin melanoma and offer the efficient informations for further designing the tyrosinase inhibitor.
Results and Discussion
The synthesis of compounds 2a-g had been described detailedly in our previous report.
20 ) The procedure for the preparation of compounds 2h-t and 3a-t was outlined in Chart 1. Briefly, compounds 2h-t were synthesized by the reacting 4-hydroxybenzaldehyde with 3-(bromomethyl)pyridine in anhydrous N,N-dimethylformamide (DMF)/NaH or the corresponding alkyl bromide in the presence of anhy-drous acetone/K 2 CO 3 . Subsequently, the reaction of obtained compounds 2a-t with thiosemicarbazide and semicarbazide to give the target compounds 3a-t and 4c, respectively. The structures of the synthesized compounds were determined by different spectroscopic techniques, like 1 H-NMR and EI-MS, and purities were confirmed by elemental analysis. 21) The inhibition of our synthetic 4-O-substituted phenylmethylenethiosemicarbazones on the diphenolase activity of mushroom tyrosinase was investigated using the usual procedure 22) and compared with tropolone, 23) one of the best tyrosinase inhibitors known so far. The IC 50 values of all obtained compounds were summarized in Table 1 . As predicted, a fair number of compounds were found to have more potent tyrosinase inhibitiory activity than phenylmethylenethiosemicarbazone (IC 50 ϭ1.93 mM). Interestingly, the IC 50 values of compounds 3a-g, 3j and 3s were of the same magnitude as tropolone (IC 50 ϭ0.42 mM). Especially, compound 3c bearing a -(CH 2 ) 2 O(CH 2 ) 2 OCH 3 group was found to be the most potent inhibitor with the IC 50 value of 0.34 mM. However, changing the number of oxygen atom and the length of alkyl part decreased the inhibitory activity on different degree. This might be due to the introduction of other substitution to impede the interaction between this molecule and the enzyme. The results suggested that tyrosinase inhibitory activity associated with the configuration of the substitution at the 4-position of benzene, and in the prensent investigation, -(CH 2 ) 2 O(CH 2 ) 2 OCH 3 group represented the most optimal structure for these compounds to exhibit remarkable tyrosinase inhibitory effects.
In addition, compounds 3i and 3k exhibited the potent tyrosinase inhibitiory activities with IC 50 values of 1.92 and 3.03 mM, respectively. Elongation of alkyl chain as in compounds 3n (IC 50 ϭ1.31 mM) and 3o (IC 50 ϭ1.09 mM) produced slight increase of tyrosinase inhibition, while further elongation of alkyl chain to give compounds 3p, 3q and 3r, which showed no tyrosinase inhibitory effect at the concentration of 200 mM. These results implied that the length of alkyl chain contained in the chain attached on position-4 of phenylmethylenethiosemicarbazone might be played a very vital role in determining their inhibitory activities, and the excessive elongation of the alkyl chain retarded the binding of inhibitor and the active site of tyrosinase, leading to a decrease of tyrosinase inhibitiory activity. Moreover, compound 3j (IC 50 ϭ0.90 mM) displayed 2.1 times higher tyrosinase inhibitory activity than compound 3i (IC 50 ϭ1.92 mM). Compound 3m (IC 50 ϭ2.21 mM) showed more potential tyrosinase inhibitory activity than compound 3k (IC 50 ϭ3.03 mM). The results suggested that the introduction of secondary alkyl group in the side chain might be beneficial to tyrosinase inhibitory activity, which supported the previous studies reported by Nihei et al. 24) Notably, compound 3l (IC 50 ϭ1.29 mM) bearing the -CH 2 CHϭCH 2 group in the side chain exhibited more potential tyrosinase inhibitory activity than 3m, indicating that the introduction of the -CH 2 CHϭCH 2 group was preferable to -CH(CH 3 ) 2 group in inhibition of tyrosinase. The reason might be that the -CH 2 CHϭCH 2 moiety formed the certain interaction with the hydrophobic protein pocket surrounding the binuclear copper active site.
To further expand the structure-activity relationships, com- 23) pounds 3s and 3t bearing a benzoxyl group were examined for the tyrosinase inhibitory activity. The results demonstrated that compounds 3s and 3t also exhibited significant inhibitory activities with are IC 50 values of 0.98 and 1.46 mM, respectively, which are more potent active than 2-(phenylmethylene)-thiosemicarbazone (IC 50 ϭ1.93 mM). However, introducing a pyridine methyleneoxyl group to position-4 of 2-(phenylmethylene)-thiosemicarbazone as in compound 3h (IC 50 ϭ 3.27 mM) led to a loss of tyrosinase inhibitory activity. It was suggested that the nature of aromatic ring might influence the tyrosinase inhibitory potency, and in the present investigation, benzoxyl group was much preferable to pyridine methyleneoxyl group in inhibition of tyrosinase. Moreover, when the thiosemicarbazide moiety of the most active compound 3c was replaced by the semicarbazide group, the obtain compound 4c was inactive at the concentration of 200 mM. The results showed that the sulfur atom of thiosemicarbazide moiety was absolutely necessarily for determining the tyrosinase inhibitory activity of these compounds, which futher supported our previous report.
18)

Conclusion
In this study, a series of 4-O-substituted phenylmethylenethiosemicarbazones were designed, synthesized and evaluated as mushroom tyrosinase inhibitors. The results demonstrated that most of compounds had potent tyrosinase inhibitory activities. Interestingly, the IC 50 values of compounds 3a-g, 3j and 3s were of the same magnitude as tropolone. Especially, compound 3c bearing a -(CH 2 ) 2 O (CH 2 ) 2 OCH 3 group was found to be the most potent inhibitor with the IC 50 value of 0.34 mM. Structure-activity relationships (SARs) analysis showed that: (1) Tyrosinase inhibitory activity associated with the configuration of the substitution at the 4-position of benzene. (2) The length of alkyl chain contained in the chain attached on position-4 of phenylmethylenethiosemicarbazone might be played a very vital role in determing the inhibitory activity. (3) The introduction of secondary alkyl group in the side chain might be beneficial to tyrosinase inhibitory activity. (4) The nature of aromatic ring might influence the tyrosinase inhibitory potency. (5) The sulfur atom of thiosemicarbazide moiety was absolutely necessary for determining the tyrosinase inhibitory activity. All these data suggested that these molecules might be utilized for the development of new candidate for the treatment of dermatological disorders. Further modification based on the current obtained SARs and evaluation of these potent compounds using a human melanoma cell line would be continued in our laboratory, and the research results will be reported in due course.
